Wall Street Analyst Initiated Plus Therapeutics Inc [PSTV]. What else is Wall St. saying

Plus Therapeutics Inc [NASDAQ: PSTV] gained 311.43% or 1.09 points to close at $1.44 with a heavy trading volume of 345990209 shares.

The daily chart for PSTV points out that the company has recorded -4.64% loss over the past six months.

If we look at the average trading volume of 174.27K shares, PSTV reached to a volume of 345990209 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Plus Therapeutics Inc [PSTV]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PSTV shares is $19.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PSTV stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Ladenburg Thalmann have made an estimate for Plus Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 25, 2021. While these analysts kept the previous recommendation, Maxim Group raised their target price to Buy. The new note on the price target was released on October 16, 2020, representing the official price target for Plus Therapeutics Inc stock.

The Average True Range (ATR) for Plus Therapeutics Inc is set at 0.21, with the Price to Sales ratio for PSTV stock in the period of the last 12 months amounting to 1.48.

Trading performance analysis for PSTV stock

Plus Therapeutics Inc [PSTV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 113.33. With this latest performance, PSTV shares gained by 15.20% in over the last four-week period, additionally sinking by -4.64% over the last 6 months – not to mention a drop of -32.39% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PSTV stock in for the last two-week period is set at 61.39, with the RSI for the last a single of trading hit 65.71, and the three-weeks RSI is set at 58.73 for Plus Therapeutics Inc [PSTV]. The present Moving Average for the last 50 days of trading for this stock 1.1218, while it was recorded at 0.6954 for the last single week of trading, and 1.4551 for the last 200 days.

Plus Therapeutics Inc [PSTV]: A deeper dive into fundamental analysis

Plus Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.44 and a Current Ratio set at 0.44.

An analysis of Institutional ownership at Plus Therapeutics Inc [PSTV]